SMMT

NASDAQSummit Therapeutics PLC
High Tide · 64Squeeze · Watch 53Neutral0 buys · $0Social · No data 0
$14.23
+$0.87 (+6.51%)
15-min delayed · Aug 26, 9:50 PMReal-time

Score summary

Buy
Analyst Ratings
13Ratings
6 Buy6 Hold1 Sell
Tide Score
64
High Tide · stable · Top 26% of universe (3931)
Outlook64High Tide · stable · Top 25% of universe (3931)
Squeeze Score
53
Watch ·
  • Days to cover8.69
  • Short interest24.58% of float
  • Borrow rate41.02%
  • Short interest trend+0.01% (30d)
Trend
Neutral
No clear trend (signals split)
Recent Smart Money
0 buys
Quiet · $0 · 14d · 4 super investors

Key statistics

Market Cap
$10.50B
52-week range
$12.43 – $26.38
14% from low
Day range
$14 – $15
Open $14.75
Volume
11.6M
vs 4.5M avg · 257%
P/E (TTM)
25.0
Fwd —
Earnings
Oct 19
53d · est $-0.22

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 13 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$23
13 Wall St 12-month targets
High
$40
Average
$26
Low
$8
$6$15$24$33$41HIGH$40MEDIAN$23LOW$7.7Feb ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 60/100 Analyst Score (Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Oct 19 (post-market, est EPS $-0.22) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.